Market

Income Statement

You can view the Income Statement for the last 5 years.

INCOME STATEMENT

GlaxoSmithKline Pharmaceuticals Ltd.

GO
Market Cap. ( ₹ in Cr. ) 46795.03 P/BV 23.98 Book Value ( ₹ ) 115.19
52 Week High/Low ( ₹ ) 3516/1921 FV/ML 10/1 P/E(X) 50.31
Book Closure 30/05/2025 EPS ( ₹ ) 54.91 Div Yield (%) 1.95
(₹ in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22
Months12121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARAR
FaceValue10.0010.0010.0010.00
     
     
INCOME    
Revenue From Operations [Net]3726.033441.773226.383264.08
Other Operating Revenues23.1811.9425.3413.95
Total Operating Revenues3749.213453.713251.723278.03
     
Other Income145.93122.59100.6675.78
Total Revenue3895.143576.303352.383353.80
     
EXPENSES    
Cost Of Materials Consumed499.90545.17427.49611.18
Purchase Of Stock-In Trade845.11853.08788.43729.44
Operating And Direct Expenses0.000.0073.850.00
Changes In Inventories Of FG,WIP And Stock-In Trade45.85-63.7268.9615.57
Employee Benefit Expenses579.70624.39594.99610.23
Finance Costs1.311.801.812.00
Depreciation And Amortisation Expenses66.7969.6865.7768.19
Other Expenses601.29586.10493.73549.73
Total Expenses2639.952616.502515.022586.33
     
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax1255.19959.80837.37767.47
     
Exceptional Items4.69-143.62-0.9711.58
Profit/Loss Before Tax1259.88816.19836.40779.05
     
Tax Expenses-Continued Operations    
Current Tax325.96237.59247.13219.74
Deferred Tax6.34-11.36-18.37-9.40
Tax For Earlier Years0.000.000.00187.94
Total Tax Expenses332.30226.23228.76398.28
Profit/Loss After Tax And Before ExtraOrdinary Items927.58589.96607.64380.77
     
Profit/Loss From Continuing Operations927.58589.96607.64380.77
     
Profit/Loss From Discontinuing Operations0.000.004.131708.18
Total Tax Expenses Discontinuing Operations0.000.001.08394.23
Net Profit/Loss From Discontinuing Operations0.000.003.041313.95
Profit/Loss For The Period927.58589.96610.691694.72
     
Minority Interest2.664.176.040.00
Consolidated Profit/Loss After MI And Associates930.24594.13616.721694.72
     
OTHER INFORMATION    
     
EARNINGS PER SHARE    
Basic EPS (Rs.)54.5241.1436.0899.29
Diluted EPS (Rs.)54.7634.8336.05100.04
     
DIVIDEND AND DIVIDEND PERCENTAGE    
Equity Share Dividend745.39542.101524.66508.22
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
  
INCOME 
Revenue From Operations [Net]3726.03
Other Operating Revenues23.18
Total Operating Revenues3749.21
Other Income145.93
Total Revenue3895.14
EXPENSES 
Cost Of Materials Consumed499.90
Purchase Of Stock-In Trade845.11
Operating And Direct Expenses0.00
Changes In Inventories Of FG,WIP And Stock-In Trade45.85
Employee Benefit Expenses579.70
Finance Costs1.31
Depreciation And Amortisation Expenses66.79
Other Expenses601.29
Total Expenses2639.95
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax1255.19
Exceptional Items4.69
Profit/Loss Before Tax1259.88
Tax Expenses-Continued Operations 
Current Tax325.96
Deferred Tax6.34
Tax For Earlier Years0.00
Total Tax Expenses332.30
Profit/Loss After Tax And Before ExtraOrdinary Items927.58
Profit/Loss From Continuing Operations927.58
Profit/Loss From Discontinuing Operations0.00
Total Tax Expenses Discontinuing Operations0.00
Net Profit/Loss From Discontinuing Operations0.00
Profit/Loss For The Period927.58
Minority Interest2.66
Consolidated Profit/Loss After MI And Associates930.24
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)54.52
Diluted EPS (Rs.)54.76
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend745.39